10. Huang MJ, Jiang Y, Liu WP, Li ZP, Li M, Zhou L, Xu Y, Yu CH, Li Q, Peng F, Liu JY, Luo F, Lu Y. Early or Up-Front Radiotherapy Improved Survival of Localized Extranodal NK/T-Cell Lymphoma, Nasal-Type in the Upper Aerodigestive Tract. Int J Radiat Oncol Biol Phys. 2008; 70 (1):166-174
11. Jiang Y, Liu C, Li JY, Huang MJ, Yao WX, Zhang R, Yao B, Du XB, Chen J, Xie K, Zhao X, Wei YQ. Different Attitudes of Chinese Patients and Their Families toward Truth Telling of Different Stages of Cancer. Psychooncology. 2007 Oct;16(10):928-36.
12. Jiang Y, Li JY, Liu C, Huang MJ, Zhou L, Li M, Zhao X, Wei YQ. Different attitudes of oncology clinicians toward truth telling of different stages of cancer. Support Care Cancer. 2006 Nov;14(11):1119-1125.
13. Jiang Yu, Wei Yu-quan, Luo Feng, et al. Gemcitabine and cisplatin in advanced nasopharyngeal carcinoma: a pilot study. Cancer Investigation. 2005，23(2): 123-128.
14. Yi T, Wei YQ, Tian L, Zhao X, Li J, Deng HX, Wen YJ, Zou CH, Tan GH, Kan B, Su JM, Jiang Y, Mao YQ, Chen P, Wang YS. Humoral and cellular immunity induced by tumor cell vaccine based on the chicken xenogeneic homologous matrix metalloproteinase-2. Cancer Gene Ther. 2007 Feb;14(2):158-64.
15. Cao M, Deng HX, Zhao J, Fan LY, Jiang Y, Wen YJ, Li J, Lei S, Mao YQ, Ding ZY, Wei YQ. Anti-tumor activity of cationic liposomes conjugated adenovirus containing CCL19 gene. Biotechnol
www.lindalemus.com Appl Biochem. 2007 Oct;48(Pt 2):109-16.
16. Wang R, Zhang XW, Wang GQ, Chen XC, Tian L, Yang HS, Hu M, Peng F, Yang JL, He QM, Zhang W, Jiang Y, Deng HX, Wen YJ, Li J, Zhao X, Wei YQ. Systemic inhibition of tumor growth by soluble Flk-1 gene therapy combined with cisplatin. Cancer Gene Ther. 2006 Oct;13(10):940-7
17. Zhang R, Tian L, Chen LJ, Xiao F, Hou JM, Zhao X, Li G, Yao B, Wen YJ, Li J, Zhang L, Chen XC, Luo F, Peng F, Jiang Y, Wei YQ. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma. Gene Ther. 2006 Sep;13(17):1263-71.
18. Luo Y, Wen YJ, Ding ZY, Fu CH, Wu Y, Liu JY, Li Q, He QM, Zhao X, Jiang Y, Li J, Deng HX, Kang B, Mao YQ, Wei YQ. Immunotherapy of tumors with protein vaccine based on chicken homologous Tie-2. Clin Cancer Res. 2006 Mar 15;12(6):1813-9.
19. Yao B, He QM, Tian L, Xiao F, Jiang Yu, Zhang R, Li G, Zhang L, Hou JM, Wang L, Cheng XC, Wen YJ, Kan B, Li J, Zhao X, Hu B, Zhou Q, Zhang L, Wei YQ. Enhanced Antitumor Effect of the Combination of Tumstatin Gene Therapy and Gemcitabine in Murine Models. Hum Gene Ther. 2005 Sep;16(9):1075-1086.
20. Li G, Tian L, Hou JM, Ding ZY, He QM, Feng P, Wen YJ, Xiao F, Yao B, Zhang R, Peng F, Jiang Yu, Luo F, Zhao X, Zhang L, Zhou Q, Wei YQ. Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors. Clin Cancer Res. 2005 Jun 1;11(11):4217-24.
21. Liu JY, Wei YQ, Yang L, Zhao X, Tian L, Hou JM, Niu T, Liu F, Jiang Y, Hu B, Wu Y, Su JM, Lou YY, He QM, Wen YJ, Yang JL, Kan B, Mao YQ, Luo F, Peng F. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood. 2003;102(5):1815-1823.
22. He QM, Wei YQ, Tian L, Zhao X, Su JM, Yang L, Lu Y, Kan B, Lou YY, Huang MJ, Xiao F, Liu JY, Hu B, Luo F, Jiang Y, Wen YJ, Deng HX, Li J, Niu T, Yang JL. Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice. J Biol Chem. 2003; 278(24):21831-21836.
23. Lu Y, Wei YQ, Tian L, Zhao X, Yang L, Hu B, Kan B, Wen YJ, Liu F, Deng HX, Li J, Mao YQ, Lei S, Huang MJ, Peng F, Jiang Y, Zhou H, Zhou LQ, Luo F. Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor. J Immunol. 2003，170(6):3162-3170.
24. Lou YY, Wei YQ, Yang L, Zhao X, Tian L, Lu Y, Wen YJ, Liu F, Huang MJ, Kang B, Xiao F, Su JM, He QM, Xie XJ, Mao YQ, Lei S, Liu JY, Lou F, Zhou LQ, Peng F, Jiang Y, Hu B. Immunogene Therapy Of Tumor With Vaccine Based On The Ligand Binding Domain Of Chicken Homologous Integrin 3. Immunol. Invest. 2002; 31(1)：51-69.
25. Peng F, Wei YQ, Tian L, Yang L, Zhao X, Lu Y, Mao YQ, Kan B, Lei S, Wang GS, Jiang Y, Wang QR, Luo F, Zou LQ, Liu JY. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand. J Cancer Res Clin Oncol. 2002 ,128(4):223-230.
26. Wei YQ, Huang MJ, Yang L, Zhao X, Tian L, Lu Y, Shu JM, Lu CJ, Niu T, Kang B, Mao YQ, Liu F, Wen YJ, Lei S, Luo F, Zhou LQ, Peng F, Jiang Y, Liu JY, Zhou H, Wang QR, He QM, Xiao F, Lou YY, Xie XJ, Li Q, Wu Y, Ding ZY, Hu B, Hu M, Zhang W. Immunogene therapy of tumors with vaccine based on xenopus homologous vascular endothelial growth factor as a model antigen. PNAS., 2001; 98(20) :11545-11550.
27. Wei YQ, Wang QR, Zhao X, Yang L, Tian L, Lu Y, Kang B, Lu CJ, Huang MJ, Lou YY, Xiao F, He QM, Shu JM, Xie XJ, Mao YQ, Lei S, Luo F, Zhou LQ, Liu CE, Zhou H, Jiang Y, Peng F, Yuan LP, Li Q, Wu Y, Liu JY. Immunotherapy of tumor with xenogeneic endothelial cells as vaccine. Nature Med., 2000; 6(10):1160-1166.
联系方式:电话： 028-85422683 邮箱:jiangyuwork@126.com
上一页 [1] [2] [3] 下一页
